In addition to the aforementioned factors, HGF was also a recurring factor in different cohort analyses, displaying both high expression in the initial mild phase of the MS group and decreased expression as patients’ conditions gradually improved (Fig. 2G and Fig. 5F). The gene discussed is HGF; the disease is myeloid sarcoma.